Case Series: The Challenge of Using Immune Checkpoint Inhibitors in Anti-Transcriptional Intermediary Factor 1 Antibody-Positive Dermatomyositis

被引：0
|
作者：
Chen, Liang [1 ]
Fallavollita, Sabrina [1 ,2 ]
Sakr, Lama [1 ,3 ]
Wang, Hangjun [1 ,4 ]
Pusztaszeri, Marc [1 ,4 ]
Esfahani, Khashayar [1 ,5 ]
Pollak, Michael N. [1 ,5 ,6 ]
Hudson, Marie [1 ,2 ,6 ]
Leclair, Valerie [1 ,2 ,6 ]
机构：
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] Jewish Gen Hosp, Div Rheumatol, Montreal, PQ, Canada
[3] Jewish Gen Hosp, Div Respirol, Montreal, PQ, Canada
[4] McGill Univ, Jewish Gen Hosp, Dept Pathol, Montreal, PQ, Canada
[5] Jewish Gen Hosp, Div Oncol, Montreal, PQ, Canada
[6] Lady Davis Inst Med Res, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2025年 / 28卷 / 01期
关键词：
dermatomyositis; immune checkpoint inhibitors; immune-related adverse events; programmed cell death 1 blockade; MALIGNANCY;
D O I：
10.1111/1756-185X.70087
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
    Lerman, Irina
    Richardson, Christopher T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [42] Anti-TIF1γ antibody-positive dermatomyositis associated with nivolumab administration in a patient with advanced oesophageal squamous cell carcinoma: A case report and literature review
    Sakurai, Takuya
    Takahashi, Junichiro
    Komatsu, Teppei
    Mitsumura, Hidetaka
    Iguchi, Yasuyuki
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (02) : 416 - 421
  • [43] Anti-TIF1γ antibody-positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
    Imai, Ryosuke
    Ikemura, Sumie
    Jinta, Torahiko
    RESPIROLOGY CASE REPORTS, 2021, 9 (04):
  • [44] Anti-MDA5 Antibody-Positive Clinically Amyopathic Dermatomyositis Associated With Multiple Heterologous Carcinomas: A Case Report
    Nakano, Yoshio
    Nishida, Koji
    Okamoto, Norio
    Gohma, Iwao
    Yasuhara, Yumiko
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [45] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [46] Anti-TIF1-γ Antibody-Positive Dermatomyositis Leading to Identification of Diffuse Large B-Cell Lymphoma
    Otsuki, Takuya
    Ishizuka, Kosuke
    Eto, Hiromitsu
    Nakano, Hiroyasu
    Kato, Yo
    Sudo, Hiroshi
    Motohashi, Iori
    Ie, Kenya
    Ohira, Yoshiyuki
    Okuse, Chiaki
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (10) : 1932 - 1936
  • [47] Association of serum IgG glycosylation with disease activity of anti-transcription intermediary factor 1 gamma positive dermatomyositis
    Li, Xi
    Bai, Jingjing
    Li, Siting
    Li, Mengtao
    Zeng, Xiaofeng
    Wang, Qian
    Hu, Chaojun
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 230 - 237
  • [48] SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-y, and Point Mutation in the Transcription Intermediary Factor 1-y Coding Gene: A Case Report
    Arnon, Johnathan
    Elia, Anna
    Nevo, Yuval
    Lossos, Alexander
    Nechushtan, Hovav
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (09):
  • [49] Effectiveness of IVIG and balloon dilation combination therapy for refractory dysphagia in anti-TIF1-gamma antibody-positive dermatomyositis
    Utsunomiya, Akira
    Koizumi, Haruka
    Iino, Shiro
    Takashima, Wataru
    Tokuriki, Atsushi
    Tokunaga, Takahiro
    Kobayashi, Namiko
    Hamaguchi, Yasuhito
    Hasegawa, Minoru
    MODERN RHEUMATOLOGY CASE REPORTS, 2018, 2 (01) : 49 - 53
  • [50] Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies
    Muro, Yoshinao
    Ishikawa, Asuka
    Sugiura, Kazumitsu
    Akiyama, Masashi
    RHEUMATOLOGY, 2012, 51 (08) : 1508 - 1513
12345